Guest guest Posted January 11, 2008 Report Share Posted January 11, 2008 could be a million things. Anemia, sugar issues, gh issues, chronic fatigue syndrome, etc... Hashi swings--please share your experience. I have hashi's, but not on meds yet.I will have several days where I feel great--plenty of energy, getlots done, sleep well, positive mood.Then I'll wake up one morning and feel dreadful--terrible fatigue,heart pounding, migrating aches and pains, difficulty sleeping.This will last a couple of days, them I'm back to feeling great againfor a few days, then I'm down again.Does this sound like Hashi's or something else? Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 11, 2008 Report Share Posted January 11, 2008 Hi , Can't remember if you mentioned this before or not - it's hard to keep track of my kids and my problems... Anyway, have you ever had the Graves' ab's tested? If so, what were the results? My Hashi/Graves' daughter does this sometimes all in the same day. I don't have to worry about loosing my hair to low thyroid as I'm pulling it out trying to find someone who can treat her effectively. She'll be cold, tired, exhausted and then all of a sudden can't sit still, nervous energy and talks so fast I don't understand her -hyper. With diet changes it's a tad bit better, but nothing to write home about. Good luck, Bj > > I have hashi's, but not on meds yet. > > I will have several days where I feel great--plenty of energy, get > lots done, sleep well, positive mood. > > Then I'll wake up one morning and feel dreadful--terrible fatigue, > heart pounding, migrating aches and pains, difficulty sleeping. > > This will last a couple of days, them I'm back to feeling great again > for a few days, then I'm down again. > > Does this sound like Hashi's or something else? > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 11, 2008 Report Share Posted January 11, 2008 Hi BJ. Yes I have TSI of 102. Do you think that is the cause? Does you daughter have the terrible fatigue, aches and pains, when she's in a downswing? > > > > I have hashi's, but not on meds yet. > > > > I will have several days where I feel great--plenty of energy, get > > lots done, sleep well, positive mood. > > > > Then I'll wake up one morning and feel dreadful--terrible fatigue, > > heart pounding, migrating aches and pains, difficulty sleeping. > > > > This will last a couple of days, them I'm back to feeling great > again > > for a few days, then I'm down again. > > > > Does this sound like Hashi's or something else? > > > > > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 11, 2008 Report Share Posted January 11, 2008 Hi , I thought TSI was universal like TSH, but it must not be. Her TSI is not near that high if that is a percentage her lab results say 38% (normal <30) and her TRAB is 27% (normal <16). She doesn't have aches per say, she feels weak like her legs won't hold her up kind of exhausted and sometimes grabs on to us to get her balance and it makes her sick to eat. If she sits down she is out " asleep " . She does sleep a lot and I am fearful of how this will affect her in a couple of years since she's so exhausted now. I think she needs to be on both thyroid replacement and anti-thyroid meds to bring down the ab levels and hopefully stablize her condition for both the hashi and Graves' but haven't found a doc who will even listen much less consider it. Bj > > > > > > I have hashi's, but not on meds yet. > > > > > > I will have several days where I feel great--plenty of energy, get > > > lots done, sleep well, positive mood. > > > > > > Then I'll wake up one morning and feel dreadful--terrible fatigue, > > > heart pounding, migrating aches and pains, difficulty sleeping. > > > > > > This will last a couple of days, them I'm back to feeling great > > again > > > for a few days, then I'm down again. > > > > > > Does this sound like Hashi's or something else? > > > > > > > > > > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 11, 2008 Report Share Posted January 11, 2008 Hi, Sounds like it might be a combination of thyroid and adrenal, since I have experienced the same and the doctor concluded that it is both of those. The things I have found most helpful for supplements (which were recommended by the doctor) were bio-identical cortisol, 5-HTP - 500 mg 2x a day, and Inositol supplements (B vitamin family) (2-3x a day 1000 mg) and 1000 mg per hour when anxiety is coming on hard. Joanna Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 11, 2008 Report Share Posted January 11, 2008 -Joanna, Yes I was thinking it there could be an adrenal component to this. I do have those supplements but I probably need to increase the inositol. I do have HC so I need to see if that will help too. I just wish there was way to know for sure while it's happening. -- In Thyroiditis , Joanna wrote: > > > Hi, > > Sounds like it might be a combination of thyroid and adrenal, since I have experienced the same and the doctor concluded that it is both of those. The things I have found most helpful for supplements (which were recommended by the doctor) were bio-identical cortisol, 5-HTP - 500 mg 2x a day, and Inositol supplements (B vitamin family) (2-3x a day 1000 mg) and 1000 mg per hour when anxiety is coming on hard. > > Joanna > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 15, 2008 Report Share Posted January 15, 2008 Hi , Those antibodies can really be tough to figure out. The best way to think about them is like this; In Graves disease, the antibodies are targetting the TSH receptors that are found on the outside of the thyroid (external) and are the 'gas pedals' for thyroid hormone production, and must be engaged to be able to make hormone. These antibodies are called TSH Receptor antibodies. In Hashimotos, the antibodies are targetting substances found in the follicular (internal) cells of the thyroid. These antibodies are called " anti-thyroid " antibodies - aka TPOab and TGab. So one type of antibody targets the INSIDE of the thyroid (and also denotes damage) and the other antibody targets the OUTSIDE of the thyroid and doesn't cause destructive damage, but controls the rate of hormone production. MORE ON TSH RECEPTOR ANTIBODIES: There are several types of TSH Receptor antibodies: Some will stimulate the receptor cells (TSI aka TSab, causing HypERthyroidism) and others will cause a decrease in hormone by blocking TSH from getting to the receptor cells (Blocking TRab) and these can cause hyPOthyroid if there is too much " blocking " going on and not enough " stimulating " . Blocking antibodies can block both TSI and TSH. Enough of them can shut down the entire hormone production. Both Blocking and Stimulating types of TRab will prevent TSH from getting to the receptors on the gland. One of assays (tests) used to measure TRab is called TBII. This test measures what percent of the TSH will be blocked (inhibited) from stimulating the TSH receptor (by the TRab antibodies). This test won't be able to tell how much of these antibodies are blocking and how much are stimulating types --- the test only measures how much TSH is being kept from binding to the site. (Which gives a round- about figure on how much TRab is attached there). Hope that was a little easier understood?? Here are some more abbreviations: Antibodies: Tgab = Thyroglobulin antibody (Marker for autoimmune-caused inflammation) One of the " anti-thyroid " antibodies TRAb = TSH receptor antibodies (directed against the TSH receptor on the thyroid & other locations) TSI = Thyroid-stimulating immunoglobulin, aka TSH-Receptor Stimulating antibody or TSab - this causes Graves hyperthyroidism (One of the TRabs) TBab = TSH-Receptor Blocking antibody, aka TSBab (One of the TRabs) TBII = thyroid-binding inhibitory immunoglobulin (TBII) - detects both classes of TRAb, including TSI and TBab. TBII Dynotest Trak (human) = this is a newer TBII assay that is reported to have a higher sensitivity to detecting all binding TRabs, including TSI. This one uses human cells in lieu of porcine cells. TPOab or Anti-TPOab = antithyroid peroxidase antibody (Marker for inflammation) One of the " anti-thyroid " antibodies AMA = antimicrosomal antibody (outdated, replaced by TPOab) Take care! Val > > Val, > As always, you are a wealth of great info. > > I really feel like I could have understood this whole antibody thing > by now, what with reading your stuff here and on Grave's group, and > the links you provide. > > But the thing keeping me from grasping is the multiple names for > several antibodies. It is confusing the heck out of me. > > I thought I remembered a chart or something you posted on Grave's that > listed the all the common names used for each antibody, but I didn't > save it and couldn't find it after that. > > Could you re-post that here? > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 15, 2008 Report Share Posted January 15, 2008 Hi Bj, First, the TBII test isn't for binding antbodies, it's to note how much TSH " binding inhibiting " is going on. (all TRab antibodies are binding type). When TRab bind, they then deflect the TSH away (this is the same location where TSH is supposed to bind). These antibodies wrest control away from the TSH, and take over. But the TBII test can't tell whether these are stimulating the receptors or doing nothing to the receptors (blocking). If you have enough TRab that are blocking (doing nothing) and they wont let any TSH in either, then the thyroid will stop functioning. TBII is " TSH-binding inhibiting immunoglobulin. They can also be called " Thyrotropin-binding inhibiting immuno " because " thyrotropin " is just the longer name for TSH. > If I understand you correctly, TRab and/or > TBII tests are not picking up the blocking receptor antibodies.< The TBII tests WILL pick up Blocking receptor abs, but when you get the range, it will be something like <17% normal. But blocking abs can be less than that and still cause plenty of trouble --- that TBII test range was built to measure how much TSH inhibiting by TSI will cause hYPER. But even a small amount of TSH-inhibiting TRab *can* cause hypO - especially if the TSI is low. And *MOST* especially if TSH is already low too. That's where I am now. I had low TSH (.30) and a TSI of 119%, with hyPO T4 and T3 numbers, so I have to take 50mcg Synthroid with 2.5mg MMI. I need to stay on the MMI to continue getting my TSI/TBII to fall. But I need the Synthroid too, because I will go hypO without any thyroid stimulation. > > What about the people who have positive TSI and positive TBII? > Wouldn't these blocking abs affect them as well?<<<< Yes ma'am. I think I was in that scenario too --- at diagnosis I had a TSI of 223% and had VERY MILD hypERthyroidism (only my T3 was elevated, but only a tiny bit. T4 was normal). Most people would have been very hypER, but not me. My first thought was that I had a damaged gland or something (I do have TPOabs). But after a year and not getting my TSH back, that was a clue that there were a lot of blocking TRabs involved. >I read through all the links and I wonder if the `blocking' abs can affect patients similarly who have all the abs for Hashi TPO/TG and the Graves' abs TSI and TRab (TBII) who aren't being treated and have never taken neither ATD nor a Thyroid replacement drug. Have you ever come across any literature on that scenario? << I have seen oodles of people who claim to be " in remission " from Graves in this exact scenario. They went on ATD long enough to see their T4 and T3 come into normal range, TSI fell, but still have plenty of TRab/TBII showing in their system -- still inhibiting the TSH from binding. Having TBII is evidence that they still have some very active autoimmune issues going on. But they can remain " euthyroid " for years like that. They sometimes even call this " Euthyroid Eye Disease " , because sometimes the titres of antibodies can be EXTREMELY high, but enough of a balance between blocking and stimulating to keep the thyroid hormones looking just fine (Normal T4 and T3). But then the eyes get really beat up in the process due to the high levels of TRab antibodies. Sometimes the worse cases of Graves eye disease is during these false " euthyroid " periods. > Every doc we've seen says this is rare especially in a young girl. >They refuse to give her ATD -it will make her HypO and Thyroid >replacement will make her HyPer and giving both is just mad medicine.< For someone dx'd as " Hashi's " , it's probably going to be really hard to convince a doc to do that. But if she has TRab and goes hypER at times,that should get him to understand that the dx would be Graves and that the best therapy is to get the thyroid under control with ATD, and then supplement with Synthroid to " force " the levels to remain stable, until the TRab go into remission. But I know how hard that is...because I'm on doc #3 right now, trying to find one who'll do just that! >>>On her lab result sheets, her tests say `thyrotropin > binding' at one lab and `TSH receptor bind' at the other. The doctor who orders her labs writes " TSH receptor binding " and " TSH receptor stimulating " for the TSI test. *So, evidently we need to add the blocking test as well. Would it be called *TSH receptor blocking* or *TSH receptor stimulating-blocking* or " TSBab* or what?? <<< It can be called any of those names (TBab, TSBab, TSH receptor blocking ab) but as far as I know, that test is not commercially available. (at least that's what the Univ of Chicago tell us, and they are the ones using B & R on kids, so they'd probably be honest) Good luck to you and your daughter! It isn't an easy task to find a doc who will listen to what you want, and then pay attention to new research you bring forth. We had to drive out of state to find our Ped Endo, and he turned out to be one that is working in labs doing research most of the time - only in the hospital clinic one day per month. I think that's the only way these docs can stay up to date on all this stuff -- it's really overwhelming -- and I only read about ONE disease! Imagine trying to keep up with several at a time? wowza. Take care! Val > > > > > > > Hi all, > > > > In the discussion on possible hyPER swings and back to hypO and > vice versa, the information I have posted below pertains to those of > your who have any detectable levels of TSI and/or TRab. I've been > recently researching this area because my TSI quickly went down after > starting ATD therapy, my TBII went from above normal to well > into " normal " range (8% - normal <17%) in just a few months, but > instead of coming into euthyriod range like I thought I would, I went > quite hypO even on tiny bits of ATD (but with low or very low- > normal TSH). > > > > I was dx'd with mild Graves in Nov 06 (with overlapping > thyroid inflammation - TPOabs) and am taking 50mcg Synthroid with > 2.5mg MMI and know that my Synthroid needs to be increased since this > dose only keeps me barely in normal range. > > > > I've read quite a bit recently that scientists are finding that > the antibody that causes Graves disease (TSI) can also switch the way > it works, and start to behave as a hyPO antibodies by blocking the > glands receptors at certain times (without causing stimulation). > This seems to occur the most shortly before the Graves disease shows > up, or some months after a Graves person starts ATD medictions. > > > > So I'm pretty sure that's where I " m at now. > > > > Sadly, some doctors wrongly assume the autoimmune > gland has atrophied anytime someone shows with hypO symptoms (due > to seeing TPOabs/TGabs) and assumes the thyroid has stopped > functioning due to damage, when it's actually it is likely that > it now is under the control of the TRab that are making it shut > down (blocking stimulation) -- and the antibody that is doing > it just might be the SAME antibody that caused the > original stimulation in the first place;  But is now attaching to a > different location on the receptor - but still blocking TSH. > > > > The part that really makes this hard to detect is that these > blocking TSI antibodies often don't show up in TBII/TRab > tests as " high " - they can be seen as low (or normal)  around 45% > and still cause a lot of symptoms - so they may get missed > completely if these aren't being picked up.  > > > > I used to think that if the TRab test or TBII test was within the > normal range (<17%), that meant you couldn't have Blocking TRab, but > now I know that isn't true and the blocking TRab seem to be highly > potent - even very small numbers can especially cause hypO effects > when the TSI is in low or negative ranges. I saw a study yesterday > where a man with GRaves disease and being treated with ATD, later > ended up needing 75mcg Synthroid to maintain euthyroid, had only > small amount of TBII, no TSI, and was highly positive for Blocking > TRab antibodies. > > > > In other words --- his TSI shifted and became blocking TRab. > > > > Only the actual " blocking TRab " (TBab) test will show for > SURE if you have these (a test which is nearly impossible to get > through commercial channels, unless you live in Japan or work in a > research lab). The man in the study above was lucky that his docs > did run blocking TRab tests and he was positive. Otherwise, they > would have just assumed his thyroid had died (due to TBII being > negative). > > > > I don't have all those studies saved (the one above), but here are > a couple others explaining the same thing: > > > > Note the the Graves disease subjects in the study below all had > positive TPOabs (which is typical), and these different types of TRab > may play a part in that destruction. > > > > http://jcem.endojournals.org/cgi/reprint/76/2/504.pdf > > > > Thyrotropin Receptor Antibodies in Hypothyroid > > > > Graves’ Disease* > > > > KANJI KASAGI, AKINARI HIDAKA, > > > > > > " ...In all patients except one, thyroid function was changeable, > with > > > > euthyroid and even subclinical hyperthyroid episodes occurring > during > > > > the course of the illness..... > > > > The possibility that TSH-blocking antibodies are a significant > > > > cause of hypothyroidism in hypothyroid Graves’ disease > > > > has been discussed (10, 18, 20). Tamai et al. (13) recently > > > > reported that approximately one third of patients with > > > > Graves’ disease who developed hypothyroidism after antithyroid > > > > drug treatment had a blocking-type TRAb. > > > > TSBAb activities were weakly and transiently positive in two of our > > cases. However, the assay was performed using samples with > > > > high TSAb activities that may have affected to some extent > > > > the accuracy of the measurement. The results of the present > > > > experiments measuring TSBAb activities in TSAb-positive > > > > samples indicate that the normal range widens as TSAb > > > > activity increases... > > > > > > And........ > > > > Negative correlation between the conversion of thyrotropin receptor- > bound blocking type thyrotropin receptor antibody (TBab) to the > stimulating type (TSI) by anti-human IgG antibodies and the > biological activity of blocking type thyrotropin receptor antibody > (TBab). > > > > Cho BY, Shong MH, Chung JH, Lee HK, Koh CS, Min HK. > > Department of Internal Medicine, Seoul National University College > of Medicine, Korea. > > > > It has been reported that receptor-bound blocking type TSH receptor > antibody (TBAb) can be converted to the stimulating type by anti- > human IgG antibodies. To evaluate the relationship between the > conversion of receptor-bound blocking type TRAb to the stimulating > type and the biological activity of blocking type TRAb, we compared > converting activities of blocking type TRAb from 10 patients with > primary nongoitrous hypothyroidism with both the doses of blocking > type TRAb which show 50% inhibition of 125I-bTSH binding to the TSH > receptor and those which show 50% inhibition of TSH-stimulated cAMP > production in cultured rat thyroid cells (FRTL-5). > > > > The additions of anti-human IgG antibody to FRTL-5 cell-bound > blocking IgGs resulted in the increase in cAMP (antibody stimulated > thyroid hormone) production in a dose-dependent manner and the > converting activities (percent increase of cAMP production) also > depended on the doses of blocking IgGs. The converting activities > were significantly correlated with the doses of blocking IgGs which > showed 50% inhibition of 125I-bTSH binding to the TSH receptor (r = > 0.71, p = 0.011). And these converting activities were also > significantly correlated with the doses of blocking IgGs which showed > 50% inhibition of TSH-stimulated cAMP increase (r = 0.81, p = 0.002), > and were negatively correlated with thyroid stimulation blocking > antibody activities (r = 0.58, p = 0.02). > > > > We have demonstrated that all cell-bound blocking type TRAb were > converted to the stimulating type by anti-human IgG antibody and the > degree of conversion was negatively correlated with the biological > activity of blocking type TRAb.(ABSTRACT TRUNCATED AT 250 WORDS) > > http://www.koreamed.org/SearchBasic.php?DT=1 & RID=89601 > > > > and.... > > > > > > > > > > Thyrotropin Receptor Antibodies in Hypothyroid > > > > Graves’ Disease* > > > > KANJI KASAGI, AKINARI HIDAKA, > > > > > > " ...In all patients except one, thyroid function was changeable, > with > > > > euthyroid and even subclinical hyperthyroid episodes occurring > during > > > > the course of the illness..... > > > > The possibility that TSH-blocking antibodies are a significant > > > > cause of hypothyroidism in hypothyroid Graves’ disease > > > > has been discussed (10, 18, 20). Tamai et al. (13) recently > > > > reported that approximately one third of patients with > > > > Graves’ disease who developed hypothyroidism after antithyroid > > > > drug treatment had a blocking-type TRAb. > > > > TSBAb activities were weakly and transiently positive in two of our > > cases. However, the assay was performed using samples with > > > > high TSAb activities that may have affected to some extent > > > > the accuracy of the measurement. The results of the present > > > > experiments measuring TSBAb activities in TSAb-positive > > > > samples indicate that the normal range widens as TSAb > > > > activity increases... > > > > > > And........ > > > > Negative correlation between the conversion of thyrotropin receptor- > bound blocking type thyrotropin receptor antibody (TBab) to the > stimulating type (TSI) by anti-human IgG antibodies and the > biological activity of blocking type thyrotropin receptor antibody > (TBab). > > > > Cho BY, Shong MH, Chung JH, Lee HK, Koh CS, Min HK. > > Department of Internal Medicine, Seoul National University College > of Medicine, Korea. > > > > It has been reported that receptor-bound blocking type TSH receptor > antibody (TBAb) can be converted to the stimulating type by anti- > human IgG antibodies. To evaluate the relationship between the > conversion of receptor-bound blocking type TRAb to the stimulating > type and the biological activity of blocking type TRAb, we compared > converting activities of blocking type TRAb from 10 patients with > primary nongoitrous hypothyroidism with both the doses of blocking > type TRAb which show 50% inhibition of 125I-bTSH binding to the TSH > receptor and those which show 50% inhibition of TSH-stimulated cAMP > production in cultured rat thyroid cells (FRTL-5). > > > > The additions of anti-human IgG antibody to FRTL-5 cell-bound > blocking IgGs resulted in the increase in cAMP (antibody stimulated > thyroid hormone) production in a dose-dependent manner and the > converting activities (percent increase of cAMP production) also > depended on the doses of blocking IgGs. The converting activities > were significantly correlated with the doses of blocking IgGs which > showed 50% inhibition of 125I-bTSH binding to the TSH receptor (r = > 0.71, p = 0.011). And these converting activities were also > significantly correlated with the doses of blocking IgGs which showed > 50% inhibition of TSH-stimulated cAMP increase (r = 0.81, p = 0.002), > and were negatively correlated with thyroid stimulation blocking > antibody activities (r = 0.58, p = 0.02). > > > > We have demonstrated that all cell-bound blocking type TRAb were > converted to the stimulating type by anti-human IgG antibody and the > degree of conversion was negatively correlated with the biological > activity of blocking type TRAb.(ABSTRACT TRUNCATED AT 250 WORDS) > > http://www.koreamed.org/SearchBasic.php?DT=1 & RID=89601 > > > > and.... > > > > > > > > And........ > > > > Negative correlation between the conversion of thyrotropin receptor- > bound blocking type thyrotropin receptor antibody (TBab) to the > stimulating type (TSI) by anti-human IgG antibodies and the > biological activity of blocking type thyrotropin receptor antibody > (TBab). > > > > Cho BY, Shong MH, Chung JH, Lee HK, Koh CS, Min HK. > > Department of Internal Medicine, Seoul National University College > of Medicine, Korea. > > > > It has been reported that receptor-bound blocking type TSH receptor > antibody (TBAb) can be converted to the stimulating type by anti- > human IgG antibodies. To evaluate the relationship between the > conversion of receptor-bound blocking type TRAb to the stimulating > type and the biological activity of blocking type TRAb, we compared > converting activities of blocking type TRAb from 10 patients with > primary nongoitrous hypothyroidism with both the doses of blocking > type TRAb which show 50% inhibition of 125I-bTSH binding to the TSH > receptor and those which show 50% inhibition of TSH-stimulated cAMP > production in cultured rat thyroid cells (FRTL-5). > > > > The additions of anti-human IgG antibody to FRTL-5 cell-bound > blocking IgGs resulted in the increase in cAMP (antibody stimulated > thyroid hormone) production in a dose-dependent manner and the > converting activities (percent increase of cAMP production) also > depended on the doses of blocking IgGs. The converting activities > were significantly correlated with the doses of blocking IgGs which > showed 50% inhibition of 125I-bTSH binding to the TSH receptor (r = > 0.71, p = 0.011). And these converting activities were also > significantly correlated with the doses of blocking IgGs which showed > 50% inhibition of TSH-stimulated cAMP increase (r = 0.81, p = 0.002), > and were negatively correlated with thyroid stimulation blocking > antibody activities (r = 0.58, p = 0.02). > > > > We have demonstrated that all cell-bound blocking type TRAb were > converted to the stimulating type by anti-human IgG antibody and the > degree of conversion was negatively correlated with the biological > activity of blocking type TRAb.(ABSTRACT TRUNCATED AT 250 WORDS) > > http://www.koreamed.org/SearchBasic.php?DT=1 & RID=89601 > > > > and.... > > > > > > Negative correlation between the conversion of thyrotropin receptor- > bound blocking type thyrotropin receptor antibody (TBab) to the > stimulating type (TSI) by anti-human IgG antibodies and the > biological activity of blocking type thyrotropin receptor antibody > (TBab). > > > > Cho BY, Shong MH, Chung JH, Lee HK, Koh CS, Min HK. > > Department of Internal Medicine, Seoul National University College > of Medicine, Korea. > > > > It has been reported that receptor-bound blocking type TSH receptor > antibody (TBAb) can be converted to the stimulating type by anti- > human IgG antibodies. To evaluate the relationship between the > conversion of receptor-bound blocking type TRAb to the stimulating > type and the biological activity of blocking type TRAb, we compared > converting activities of blocking type TRAb from 10 patients with > primary nongoitrous hypothyroidism with both the doses of blocking > type TRAb which show 50% inhibition of 125I-bTSH binding to the TSH > receptor and those which show 50% inhibition of TSH-stimulated cAMP > production in cultured rat thyroid cells (FRTL-5). > > > > The additions of anti-human IgG antibody to FRTL-5 cell-bound > blocking IgGs resulted in the increase in cAMP (antibody stimulated > thyroid hormone) production in a dose-dependent manner and the > converting activities (percent increase of cAMP production) also > depended on the doses of blocking IgGs. The converting activities > were significantly correlated with the doses of blocking IgGs which > showed 50% inhibition of 125I-bTSH binding to the TSH receptor (r = > 0.71, p = 0.011). And these converting activities were also > significantly correlated with the doses of blocking IgGs which showed > 50% inhibition of TSH-stimulated cAMP increase (r = 0.81, p = 0.002), > and were negatively correlated with thyroid stimulation blocking > antibody activities (r = 0.58, p = 0.02). > > > > We have demonstrated that all cell-bound blocking type TRAb were > converted to the stimulating type by anti-human IgG antibody and the > degree of conversion was negatively correlated with the biological > activity of blocking type TRAb.(ABSTRACT TRUNCATED AT 250 WORDS) > > http://www.koreamed.org/SearchBasic.php?DT=1 & RID=89601 > > > > and.... > > > > Serum Thyrotropin Receptor Antibodies (TRab) Concentrations in > Patients with Graves' Disease Before, at the End of Methimazole > Treatment, and After Drug Withdrawal: Evidence That the Activity of > Thyrotropin Receptor Antibody (TRab) and/or Thyroid Response, Modify > During the Observation Period > > > > C. Carella, G. Mazziotti, F. Sorvillo, M. Piscopo, M. Cioffi, > P. Pilla, R. Nersita, S. Iorio, G. Amato, L.E. Braverman, > E. Roti > > > > Thyroid. Mar 2006, Vol. 16, No. 3: 295-302 > > http://www.liebertonline.com/doi/abs/10.1089/thy.2006.16.295 > > > > And....... > > > > http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1808638 > > Elevated ANA levels were associated with the atrophic variant > of autoimmune thyroid disease and may affect the volume of the > thyroid gland, and there was no statistically significant association > to the HLA system. > > > > > > > > > > > > > ______________________________________________________________________ > __ > > More new features than ever. Check out the new AOL Mail ! - > http://webmail.aol.com > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 15, 2008 Report Share Posted January 15, 2008 Hi Val, Thanks for the reply. Actually, most doc's say she has Graves' as the leader w/Hashi inflammation. Her TSH is .09 FT4- .9 (.08-1.8) FT3- 3.9 (2.3-4.2) TPOab- 3057 (<35) TGab- 1324 (<40) TSI- 138% (<130%) TBII- 27% (<16) So which of the thyrotrophin receptors antibodies, stimulating or blocking, would you be inclined to think are dominant? I think it must be the blocking from her symptoms. A couple doc's think she has Hashitoxicosis, a couple say just take her thyroid out, others want to give her a small dose of RAI to get it working again. Yeah – Right! Yes, you read that right – I was flabbergasted when the first one mentioned it, especially since he's a naturopathic doc. I wanted an ultrasound, but one hasn't been ordered so far. Thanks again for your input. Bj > > > > > > > > > Hi all, > > > > > > In the discussion on possible hyPER swings and back to hypO and > > vice versa, the information I have posted below pertains to those > of > > your who have any detectable levels of TSI and/or TRab. I've been > > recently researching this area because my TSI quickly went down > after > > starting ATD therapy, my TBII went from above normal to well > > into " normal " range (8% - normal <17%) in just a few months, but > > instead of coming into euthyriod range like I thought I would, I > went > > quite hypO even on tiny bits of ATD (but with low or very low- > > normal TSH). > > > > > > I was dx'd with mild Graves in Nov 06 (with overlapping > > thyroid inflammation - TPOabs) and am taking 50mcg Synthroid with > > 2.5mg MMI and know that my Synthroid needs to be increased since > this > > dose only keeps me barely in normal range. > > > > > > I've read quite a bit recently that scientists are finding that > > the antibody that causes Graves disease (TSI) can also switch the > way > > it works, and start to behave as a hyPO antibodies by blocking the > > glands receptors at certain times (without causing stimulation). > > This seems to occur the most shortly before the Graves disease > shows > > up, or some months after a Graves person starts ATD medictions. > > > > > > So I'm pretty sure that's where I " m at now. > > > > > > Sadly, some doctors wrongly assume the autoimmune > > gland has atrophied anytime someone shows with hypO symptoms (due > > to seeing TPOabs/TGabs) and assumes the thyroid has stopped > > functioning due to damage, when it's actually it is likely that > > it now is under the control of the TRab that are making it shut > > down (blocking stimulation) -- and the antibody that is doing > > it just might be the SAME antibody that caused the > > original stimulation in the first place;  But is now attaching to > a > > different location on the receptor - but still blocking TSH. > > > > > > The part that really makes this hard to detect is that these > > blocking TSI antibodies often don't show up in TBII/TRab > > tests as " high " - they can be seen as low (or normal) >  around 45% > > and still cause a lot of symptoms - so they may get missed > > completely if these aren't being picked up.  > > > > > > I used to think that if the TRab test or TBII test was within > the > > normal range (<17%), that meant you couldn't have Blocking TRab, > but > > now I know that isn't true and the blocking TRab seem to be highly > > potent - even very small numbers can especially cause hypO effects > > when the TSI is in low or negative ranges. I saw a study yesterday > > where a man with GRaves disease and being treated with ATD, later > > ended up needing 75mcg Synthroid to maintain euthyroid, had only > > small amount of TBII, no TSI, and was highly positive for Blocking > > TRab antibodies. > > > > > > In other words --- his TSI shifted and became blocking TRab. > > > > > > Only the actual " blocking TRab " (TBab) test will show for > > SURE if you have these (a test which is nearly impossible to get > > through commercial channels, unless you live in Japan or work in a > > research lab). The man in the study above was lucky that his docs > > did run blocking TRab tests and he was positive. Otherwise, they > > would have just assumed his thyroid had died (due to TBII being > > negative). > > > > > > I don't have all those studies saved (the one above), but here > are > > a couple others explaining the same thing: > > > > > > Note the the Graves disease subjects in the study below all had > > positive TPOabs (which is typical), and these different types of > TRab > > may play a part in that destruction. > > > > > > http://jcem.endojournals.org/cgi/reprint/76/2/504.pdf > > > > > > Thyrotropin Receptor Antibodies in Hypothyroid > > > > > > Graves’ Disease* > > > > > > KANJI KASAGI, AKINARI HIDAKA, > > > > > > > > > " ...In all patients except one, thyroid function was changeable, > > with > > > > > > euthyroid and even subclinical hyperthyroid episodes occurring > > during > > > > > > the course of the illness..... > > > > > > The possibility that TSH-blocking antibodies are a significant > > > > > > cause of hypothyroidism in hypothyroid Graves’ disease > > > > > > has been discussed (10, 18, 20). Tamai et al. (13) recently > > > > > > reported that approximately one third of patients with > > > > > > Graves’ disease who developed hypothyroidism after antithyroid > > > > > > drug treatment had a blocking-type TRAb. > > > > > > TSBAb activities were weakly and transiently positive in two of > our > > > cases. However, the assay was performed using samples with > > > > > > high TSAb activities that may have affected to some extent > > > > > > the accuracy of the measurement. The results of the present > > > > > > experiments measuring TSBAb activities in TSAb-positive > > > > > > samples indicate that the normal range widens as TSAb > > > > > > activity increases... > > > > > > > > > And........ > > > > > > Negative correlation between the conversion of thyrotropin > receptor- > > bound blocking type thyrotropin receptor antibody (TBab) to the > > stimulating type (TSI) by anti-human IgG antibodies and the > > biological activity of blocking type thyrotropin receptor antibody > > (TBab). > > > > > > Cho BY, Shong MH, Chung JH, Lee HK, Koh CS, Min HK. > > > Department of Internal Medicine, Seoul National University > College > > of Medicine, Korea. > > > > > > It has been reported that receptor-bound blocking type TSH > receptor > > antibody (TBAb) can be converted to the stimulating type by anti- > > human IgG antibodies. To evaluate the relationship between the > > conversion of receptor-bound blocking type TRAb to the stimulating > > type and the biological activity of blocking type TRAb, we compared > > converting activities of blocking type TRAb from 10 patients with > > primary nongoitrous hypothyroidism with both the doses of blocking > > type TRAb which show 50% inhibition of 125I-bTSH binding to the TSH > > receptor and those which show 50% inhibition of TSH-stimulated cAMP > > production in cultured rat thyroid cells (FRTL-5). > > > > > > The additions of anti-human IgG antibody to FRTL-5 cell-bound > > blocking IgGs resulted in the increase in cAMP (antibody stimulated > > thyroid hormone) production in a dose-dependent manner and the > > converting activities (percent increase of cAMP production) also > > depended on the doses of blocking IgGs. The converting activities > > were significantly correlated with the doses of blocking IgGs which > > showed 50% inhibition of 125I-bTSH binding to the TSH receptor (r = > > 0.71, p = 0.011). And these converting activities were also > > significantly correlated with the doses of blocking IgGs which > showed > > 50% inhibition of TSH-stimulated cAMP increase (r = 0.81, p = > 0.002), > > and were negatively correlated with thyroid stimulation blocking > > antibody activities (r = 0.58, p = 0.02). > > > > > > We have demonstrated that all cell-bound blocking type TRAb were > > converted to the stimulating type by anti-human IgG antibody and > the > > degree of conversion was negatively correlated with the biological > > activity of blocking type TRAb.(ABSTRACT TRUNCATED AT 250 WORDS) > > > http://www.koreamed.org/SearchBasic.php?DT=1 & RID=89601 > > > > > > and.... > > > > > > > > > > > > > > > Thyrotropin Receptor Antibodies in Hypothyroid > > > > > > Graves’ Disease* > > > > > > KANJI KASAGI, AKINARI HIDAKA, > > > > > > > > > " ...In all patients except one, thyroid function was changeable, > > with > > > > > > euthyroid and even subclinical hyperthyroid episodes occurring > > during > > > > > > the course of the illness..... > > > > > > The possibility that TSH-blocking antibodies are a significant > > > > > > cause of hypothyroidism in hypothyroid Graves’ disease > > > > > > has been discussed (10, 18, 20). Tamai et al. (13) recently > > > > > > reported that approximately one third of patients with > > > > > > Graves’ disease who developed hypothyroidism after antithyroid > > > > > > drug treatment had a blocking-type TRAb. > > > > > > TSBAb activities were weakly and transiently positive in two of > our > > > cases. However, the assay was performed using samples with > > > > > > high TSAb activities that may have affected to some extent > > > > > > the accuracy of the measurement. The results of the present > > > > > > experiments measuring TSBAb activities in TSAb-positive > > > > > > samples indicate that the normal range widens as TSAb > > > > > > activity increases... > > > > > > > > > And........ > > > > > > Negative correlation between the conversion of thyrotropin > receptor- > > bound blocking type thyrotropin receptor antibody (TBab) to the > > stimulating type (TSI) by anti-human IgG antibodies and the > > biological activity of blocking type thyrotropin receptor antibody > > (TBab). > > > > > > Cho BY, Shong MH, Chung JH, Lee HK, Koh CS, Min HK. > > > Department of Internal Medicine, Seoul National University > College > > of Medicine, Korea. > > > > > > It has been reported that receptor-bound blocking type TSH > receptor > > antibody (TBAb) can be converted to the stimulating type by anti- > > human IgG antibodies. To evaluate the relationship between the > > conversion of receptor-bound blocking type TRAb to the stimulating > > type and the biological activity of blocking type TRAb, we compared > > converting activities of blocking type TRAb from 10 patients with > > primary nongoitrous hypothyroidism with both the doses of blocking > > type TRAb which show 50% inhibition of 125I-bTSH binding to the TSH > > receptor and those which show 50% inhibition of TSH-stimulated cAMP > > production in cultured rat thyroid cells (FRTL-5). > > > > > > The additions of anti-human IgG antibody to FRTL-5 cell-bound > > blocking IgGs resulted in the increase in cAMP (antibody stimulated > > thyroid hormone) production in a dose-dependent manner and the > > converting activities (percent increase of cAMP production) also > > depended on the doses of blocking IgGs. The converting activities > > were significantly correlated with the doses of blocking IgGs which > > showed 50% inhibition of 125I-bTSH binding to the TSH receptor (r = > > 0.71, p = 0.011). And these converting activities were also > > significantly correlated with the doses of blocking IgGs which > showed > > 50% inhibition of TSH-stimulated cAMP increase (r = 0.81, p = > 0.002), > > and were negatively correlated with thyroid stimulation blocking > > antibody activities (r = 0.58, p = 0.02). > > > > > > We have demonstrated that all cell-bound blocking type TRAb were > > converted to the stimulating type by anti-human IgG antibody and > the > > degree of conversion was negatively correlated with the biological > > activity of blocking type TRAb.(ABSTRACT TRUNCATED AT 250 WORDS) > > > http://www.koreamed.org/SearchBasic.php?DT=1 & RID=89601 > > > > > > and.... > > > > > > > > > > > > And........ > > > > > > Negative correlation between the conversion of thyrotropin > receptor- > > bound blocking type thyrotropin receptor antibody (TBab) to the > > stimulating type (TSI) by anti-human IgG antibodies and the > > biological activity of blocking type thyrotropin receptor antibody > > (TBab). > > > > > > Cho BY, Shong MH, Chung JH, Lee HK, Koh CS, Min HK. > > > Department of Internal Medicine, Seoul National University > College > > of Medicine, Korea. > > > > > > It has been reported that receptor-bound blocking type TSH > receptor > > antibody (TBAb) can be converted to the stimulating type by anti- > > human IgG antibodies. To evaluate the relationship between the > > conversion of receptor-bound blocking type TRAb to the stimulating > > type and the biological activity of blocking type TRAb, we compared > > converting activities of blocking type TRAb from 10 patients with > > primary nongoitrous hypothyroidism with both the doses of blocking > > type TRAb which show 50% inhibition of 125I-bTSH binding to the TSH > > receptor and those which show 50% inhibition of TSH-stimulated cAMP > > production in cultured rat thyroid cells (FRTL-5). > > > > > > The additions of anti-human IgG antibody to FRTL-5 cell-bound > > blocking IgGs resulted in the increase in cAMP (antibody stimulated > > thyroid hormone) production in a dose-dependent manner and the > > converting activities (percent increase of cAMP production) also > > depended on the doses of blocking IgGs. The converting activities > > were significantly correlated with the doses of blocking IgGs which > > showed 50% inhibition of 125I-bTSH binding to the TSH receptor (r = > > 0.71, p = 0.011). And these converting activities were also > > significantly correlated with the doses of blocking IgGs which > showed > > 50% inhibition of TSH-stimulated cAMP increase (r = 0.81, p = > 0.002), > > and were negatively correlated with thyroid stimulation blocking > > antibody activities (r = 0.58, p = 0.02). > > > > > > We have demonstrated that all cell-bound blocking type TRAb were > > converted to the stimulating type by anti-human IgG antibody and > the > > degree of conversion was negatively correlated with the biological > > activity of blocking type TRAb.(ABSTRACT TRUNCATED AT 250 WORDS) > > > http://www.koreamed.org/SearchBasic.php?DT=1 & RID=89601 > > > > > > and.... > > > > > > > > > Negative correlation between the conversion of thyrotropin > receptor- > > bound blocking type thyrotropin receptor antibody (TBab) to the > > stimulating type (TSI) by anti-human IgG antibodies and the > > biological activity of blocking type thyrotropin receptor antibody > > (TBab). > > > > > > Cho BY, Shong MH, Chung JH, Lee HK, Koh CS, Min HK. > > > Department of Internal Medicine, Seoul National University > College > > of Medicine, Korea. > > > > > > It has been reported that receptor-bound blocking type TSH > receptor > > antibody (TBAb) can be converted to the stimulating type by anti- > > human IgG antibodies. To evaluate the relationship between the > > conversion of receptor-bound blocking type TRAb to the stimulating > > type and the biological activity of blocking type TRAb, we compared > > converting activities of blocking type TRAb from 10 patients with > > primary nongoitrous hypothyroidism with both the doses of blocking > > type TRAb which show 50% inhibition of 125I-bTSH binding to the TSH > > receptor and those which show 50% inhibition of TSH-stimulated cAMP > > production in cultured rat thyroid cells (FRTL-5). > > > > > > The additions of anti-human IgG antibody to FRTL-5 cell-bound > > blocking IgGs resulted in the increase in cAMP (antibody stimulated > > thyroid hormone) production in a dose-dependent manner and the > > converting activities (percent increase of cAMP production) also > > depended on the doses of blocking IgGs. The converting activities > > were significantly correlated with the doses of blocking IgGs which > > showed 50% inhibition of 125I-bTSH binding to the TSH receptor (r = > > 0.71, p = 0.011). And these converting activities were also > > significantly correlated with the doses of blocking IgGs which > showed > > 50% inhibition of TSH-stimulated cAMP increase (r = 0.81, p = > 0.002), > > and were negatively correlated with thyroid stimulation blocking > > antibody activities (r = 0.58, p = 0.02). > > > > > > We have demonstrated that all cell-bound blocking type TRAb were > > converted to the stimulating type by anti-human IgG antibody and > the > > degree of conversion was negatively correlated with the biological > > activity of blocking type TRAb.(ABSTRACT TRUNCATED AT 250 WORDS) > > > http://www.koreamed.org/SearchBasic.php?DT=1 & RID=89601 > > > > > > and.... > > > > > > Serum Thyrotropin Receptor Antibodies (TRab) Concentrations in > > Patients with Graves' Disease Before, at the End of Methimazole > > Treatment, and After Drug Withdrawal: Evidence That the Activity of > > Thyrotropin Receptor Antibody (TRab) and/or Thyroid Response, > Modify > > During the Observation Period > > > > > > C. Carella, G. Mazziotti, F. Sorvillo, M. Piscopo, > M. Cioffi, > > P. Pilla, R. Nersita, S. Iorio, G. Amato, L.E. Braverman, > > E. Roti > > > > > > Thyroid. Mar 2006, Vol. 16, No. 3: 295-302 > > > http://www.liebertonline.com/doi/abs/10.1089/thy.2006.16.295 > > > > > > And....... > > > > > > http://www.pubmedcentral.nih.gov/articlerender.fcgi? artid=1808638 > > > Elevated ANA levels were associated with the atrophic variant > > of autoimmune thyroid disease and may affect the volume of the > > thyroid gland, and there was no statistically significant > association > > to the HLA system. > > > > > > > > > > > > > > > > > > > > > ______________________________________________________________________ > > __ > > > More new features than ever. Check out the new AOL Mail ! - > > http://webmail.aol.com > > > > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 16, 2008 Report Share Posted January 16, 2008  Yes, that is what I said, that I've been thinking for quite some time that I probably had/have Grave's also. Also, I just went back to the HealthCheck site, which I haven't been on in quite some time, or at least looked up these tests. It was I who ran the TPO and the TG antibodies testing through them and found out myself that I definitely have Hashi's (antibodies to both in the thousands for both), and, at that time (3 to 4 yrs ago), they had published on their site the combo panel for TSI AND TBab, done together. I just went back to the site, and, low and behold, they are no longer running that blocking antibody. They have always said, however, if they are not displaying a particular test, to call them, and they may be running that test, just not displaying it on their web site. I've been over virtually every test on that site, and it was there, but no longer. Why would they pull this off of their site, I wonder. Hmm, think I'll give them a call. Too bad I didn't have both of those run back when I had the other two done, I just didn't know to. Drats. Re: Hashi swings--please share your experience. Hi , Several comments you made in your post are signs that you may well have Graves and Hasih's both. In fact, 95% of people with Graves have Hashi's too, since Hashi's means simply, inflammation of the thyroid gland targetted by immune cells. Some even think that ALL Graves people have Hashi's -- since they know (through biopsy) that sometimes TPOab antibodies can stay within the realm of the thyroid and don't get picked up in blood tests.But back to the TBII/TRab testing. The blocking TRabs that cause hyPO in Graves people are called TBab or sometimes TSBab. (TSH-Receptor blocking antibodies). The test for these is nearly impossible to find in the USA. However, there are "TOTAL" TSH-Receptor antibody tests you can get, but these will pick up all types of TSH-Receptor antibodies (stimulating and blocking). This test is also known as TBII, which measures how much TSH will be deflected (inhibited) away from binding to the thyroid's TSH-receptor cells (by the TRab that have already attached themselves there).These TRab/TBII can also confuse the pituitary gland in the same way it causes the thyroid to be confused. This often causes the pituitary to cut down production of TSH. (but not in every case).HOWEVER --- Blocking TRab are now known to cause much more hypO effect than first thought. It doesn't take much at all. So a TBII test that shows less than 17% (what they consider normal) doesn't mean there are no blocking TRab in that result. You can sometimes have Blocking TRab that is only half as much as the TSI to cause a hyPO effect. So the TBII might show 8% (<17% normal) and yet you can still be affected by Blocking TRab. But remember that TBII (TRab) test will pick up the TOTAL of all of the TRab -- so you will need a TSI test to measure against that too.Yes, you can get the TBII/TRab test from Healthcheck, but you cannot get the test that only measures just the blocking TRab from Healthcheck. You can also get the test for only the stimulating (hyPER-causing) type of TRab -- that one is called TSI.Since TBII/TRab affect the TSH-Receptor cells of both the pituitary and the thyroid (and eyes, skin, brain, thymus and even yet undiscovered places where we might have TSH-Receptor cells) if you have a consistently low TSH, then it's highly likely you have TRab that is messing with both the thyroid and the pituitary. Hope that helps!Here's some info about that...from the Journal of Clinical Endocrinology & Metabolismhttp://jcem.endojournals.org/cgi/content/full/86/10/4814".....we recently showed that the pituitary contains a TSH receptor through which TSH secretion may be down-regulated via a paracrine feedback loop. In Graves’ disease, TSH receptor autoantibodies may also bind this pituitary receptor, thus causing continued TSH suppression."Take care!Val Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 17, 2008 Report Share Posted January 17, 2008 Hi , I dont believe Healthcheck has ever offered the blocking TRab antibody test, as far as I can remember. They run the stimulating TRab (called TSI) and they also run the TOTAL TRab (TBII, which includes blocking and stimulating). The total TRab assay they use is called TBII (This means " TRab antibodies that inhibit TSH from binding to the TSH receptors on the thyroid " ). " TSH-binding inhibiting immunoglobulin " . Healthcheck does still offer the TBII, but you have to call them directly to order it. As far as I know there isn't a commercialy available test for Blocking TRab only. Researchers have access, but not for standard practice - as far as I know (I think they are working on this). But when you get both TSI and TBII run, and you have very low TSI but detectable TBII, with hypO labs (and maybe even low TSH), that's a clue you do have Blocking TRab. My son's TPOabs were 20,000 at diagnosis of hyPER, felll to 1200 during ATD therapy (3.5 yrs), then went back up to 20,000 when he went into remission and stopped ATD. But he doesn't have any thyroid issues now (in remission from Graves 19 mo's). His endo told me the quantity of TPoabs isn't how you can judge the degree of thyroid damage because some cells might have a lot more TPO (thyroglobulin) than others, and if that one cell breaks it will cause a massive increase in antibodies against thyroperoxidase - but one broken cell isn't enough to alter thyroid function. However, the one broken cell *does* denote we are experiencing inflammation. But if we want to see if that damage is occuring to a major degree, we'd have to get a biopsy or scan. The antibody numbers - no matter how high - won't be able to tell us how many cells are being destroyed. Did you know that 95% of people with Graves have TPOabs (me included)? And they now think the other 5% may have them too, but they don't leave the thyroid area (Sometimes found during thyroid biopsy in TPOab-Neg people). Mine were 1250 at dx, and went down to 400 during ATD therapy (due to immunosuppression). Not sure what they are now (still on ATD + Synthroid). But the fact I have them means my thyroid has some inflammation. Hope that helps! Val Re: Hashi swings--please share your experience. Posted by: " " marin@... lilacs150 Wed Jan 16, 2008 6:18 am (PST) Yes, that is what I said, that I've been thinking for quite some time that I probably had/have Grave's also. Also, I just went back to the HealthCheck site, which I haven't been on in quite some time, or at least looked up these tests. It was I who ran the TPO and the TG antibodies testing through them and found out myself that I definitely have Hashi's (antibodies to both in the thousands for both), and, at that time (3 to 4 yrs ago), they had published on their site the combo panel for TSI AND TBab, done together. I just went back to the site, and, low and behold, they are no longer running that blocking antibody. They have always said, however, if they are not displaying a particular test, to call them, and they may be running that test, just not displaying it on their web site. I've been over virtually every test on that site, and it was there, but no longer. Why would they pull this off of their site, I wonder. Hmm, think I'll give them a call. Too bad I didn't have both of those run back when I had the other two done, I just didn't know to. Drats. ________________________________________________________________________ More new features than ever. Check out the new AOL Mail ! - http://webmail.aol.com Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 18, 2008 Report Share Posted January 18, 2008 Val, Thanks for this great explanation. This makes it much more clear. > > Hi , > > Those antibodies can really be tough to figure out. > > The best way to think about them is like this; > > > In Graves disease, the antibodies are targetting the TSH receptors > that are found on the outside of the thyroid (external) and are > the 'gas pedals' for thyroid hormone production, and must be engaged > to be able to make hormone. These antibodies are called TSH Receptor > antibodies. > > In Hashimotos, the antibodies are targetting substances found in the > follicular (internal) cells of the thyroid. These antibodies are > called " anti-thyroid " antibodies - aka TPOab and TGab. > > So one type of antibody targets the INSIDE of the thyroid (and also > denotes damage) and the other antibody targets the OUTSIDE of the > thyroid and doesn't cause destructive damage, but controls the rate > of hormone production. > > > MORE ON TSH RECEPTOR ANTIBODIES: > > > > There are several types of TSH Receptor antibodies: Some will > stimulate the receptor cells (TSI aka TSab, causing HypERthyroidism) > and others will cause a decrease in hormone by blocking TSH from > getting to the receptor cells (Blocking TRab) and these can cause > hyPOthyroid if there is too much " blocking " going on and not > enough " stimulating " . Blocking antibodies can block both TSI and > TSH. Enough of them can shut down the entire hormone production. > > Both Blocking and Stimulating types of TRab will prevent TSH from > getting to the receptors on the gland. > > One of assays (tests) used to measure TRab is called TBII. This test > measures what percent of the TSH will be blocked (inhibited) from > stimulating the TSH receptor (by the TRab antibodies). This test > won't be able to tell how much of these antibodies are blocking and > how much are stimulating types --- the test only measures how much > TSH is being kept from binding to the site. (Which gives a round- > about figure on how much TRab is attached there). > > > Hope that was a little easier understood?? > > Here are some more abbreviations: > > Antibodies: > Tgab = Thyroglobulin antibody (Marker for autoimmune-caused > inflammation) One of the " anti-thyroid " antibodies > TRAb = TSH receptor antibodies (directed against the TSH receptor on > the thyroid & other locations) > TSI = Thyroid-stimulating immunoglobulin, aka TSH-Receptor > Stimulating antibody or TSab - this causes Graves hyperthyroidism > (One of the TRabs) > TBab = TSH-Receptor Blocking antibody, aka TSBab (One of the TRabs) > TBII = thyroid-binding inhibitory immunoglobulin (TBII) - detects > both classes of TRAb, including TSI and TBab. > TBII Dynotest Trak (human) = this is a newer TBII assay that is > reported to have a higher sensitivity to detecting all binding > TRabs, including TSI. This one uses human cells in lieu of porcine > cells. > TPOab or Anti-TPOab = antithyroid peroxidase antibody (Marker for > inflammation) One of the " anti-thyroid " antibodies > AMA = antimicrosomal antibody (outdated, replaced by TPOab) > > Take care! > Val > > Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.